Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Condensed Consolidated Statements of Operations (Unaudited)
Revenues	$ 9,646	$ 7,501	$ 17,643	$ 14,723
Cost of goods sold	7,062	6,029	12,845	11,519
Gross profit	2,584	1,472	4,798	3,204
Operating expenses:
Selling, general and administrative	3,689	3,610	7,114	7,748
Professional fees	798	507	1,600	964
Impairment of property, plant and equipment	0	1,000	0	1,000
Settlement with former customer	0	0	(800)	0
Loss on disposal of property, plant and equipment	0	27	0	403
Provision for doubtful accounts	72	50	132	123
Total operating expenses	4,559	5,194	8,046	10,238
Loss from operations	(1,975)	(3,722)	(3,248)	(7,034)
Other income (expense):
Interest income	67	4	80	17
Interest expense	(424)	(300)	(812)	(581)
Loss on acquisition of additional interests in Rice Rx	(140)	0	(140)	0
Loss on equity method investments	(12)	(10)	(25)	(21)
Warrant liability income (expense)	2,436	(508)	(141)	(187)
Gain on extinguishment of debt	265	0	265	0
Other income	53	107	155	230
Other expense	(250)	0	(261)	(30)
Total other income (expense)	1,995	(707)	(879)	(572)
Reorganization expenses - professional fees	0	399	0	736
Income (loss) before income taxes	20	(4,828)	(4,127)	(8,342)
Income tax benefit (expense)	(52)	300	8	544
Net loss	(32)	(4,528)	(4,119)	(7,798)
Net loss attributable to noncontrolling interest in Nutra SA	11	0	39	0
Net loss attributable to NutraCea shareholders	$ (21)	$ (4,528)	$ (4,080)	$ (7,798)
Loss per share attributable to NutraCea shareholders
Basic (in dollars per share)	$ 0.00	$ (0.02)	$ (0.02)	$ (0.04)
Diluted (in dollars per share)	$ 0.00	$ (0.02)	$ (0.02)	$ (0.04)
Weighted average number of shares outstanding
Basic (in shares)	198,310	193,028	196,767	193,010
Diluted (in shares)	198,310	193,028	196,767	193,010